Your browser doesn't support javascript.
loading
Genetic Characterization of Kidney Failure of Unknown Etiology in Spain: Findings From the GENSEN Study.
Blasco, Miquel; Quiroga, Borja; García-Aznar, José M; Castro-Alonso, Cristina; Fernández-Granados, Saulo J; Luna, Enrique; Fernández Fresnedo, Gema; Ossorio, Marta; Izquierdo, María Jesús; Sanchez-Ospina, Didier; Castañeda-Infante, Laura; Mouzo, Ricardo; Cao, Mercedes; Besada-Cerecedo, María L; Pan-Lizcano, Ricardo; Torra, Roser; Ortiz, Alberto; de Sequera, Patricia.
Afiliación
  • Blasco M; Nephrology and Kidney Transplant Department. National Reference Center for Complex Glomerular Diseases (CSUR). Hospital Clínic, Barcelona University, Barcelona, Spain; Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spain; RICO
  • Quiroga B; RICORS2040, Madrid, Spain; IIS-La Princesa. Servicio de Nefrología, Hospital Universitario de la Princesa, Madrid, Spain.
  • García-Aznar JM; (H)ealthincode. Clinical Area of Genetic Diagnostic in Nephrology and Immunology, A Coruña, Spain.
  • Castro-Alonso C; Department of Nephrology. Doctor Peset University Hospital. Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO) Valencia, Spain.
  • Fernández-Granados SJ; Hospital Universitario Insular de Gran Canaria, Nephrology Service, Las Palmas de Gran Canaria, Las Palmas, Spain.
  • Luna E; Complejo Hospitalario Universitario de Badajoz, Unidad enfermedades genéticas renales, Servicio de Nefrologia. Badajoz, Spain.
  • Fernández Fresnedo G; Nephrology Department,Hospital Marqués de Valdecilla-Grupo de Inmunopatología IDIVAL,Santander,Spain.
  • Ossorio M; Nephrology Department, Hospital Universitario La Paz, Madrid, Spain.
  • Izquierdo MJ; Nephrology Department, Burgos University Hospital, Burgos, Spain.
  • Sanchez-Ospina D; Clinical Analysis Service, Burgos University Hospital, Spain.
  • Castañeda-Infante L; Nephrology Department, Clínica Universitaria de Navarra, Pamplona, Spain.
  • Mouzo R; Nephrology Department, Hospital El Bierzo, Ponferrada, Spain.
  • Cao M; Nephrology Department, Complexo Hospitalario Universitario A Coruña, A Coruña, Spain.
  • Besada-Cerecedo ML; Healthincode, Clinical Genetic Diagnosis department, La Coruña, Spain.
  • Pan-Lizcano R; Healthincode, Clinical Genetic Diagnosis department, La Coruña, Spain.
  • Torra R; RICORS2040, Madrid, Spain; Inherited kidney diseases, Nephrology Department, Fundació Puigvert. Institut de Recerca Sant Pau. Medicine Department, Universitat Autònoma de Barcelona (UAB). Spain.
  • Ortiz A; RICORS2040, Madrid, Spain; Nephrology and Hypertension Department, IIS-Fundación Jiménez Díaz UAM, Madrid, Spain; Medicine Department, Facultad de Medicina, Universidad Autónoma de Madrid, Madrid, Spain. Electronic address: aortiz@fjd.es.
  • de Sequera P; RICORS2040, Madrid, Spain; Nephrology Department,Hospital Universitario Infanta Leonor,Madrid,Spain; Universidad Complutense de Madrid,Madrid,Spain. Electronic address: psequerao@senefro.org.
Am J Kidney Dis ; 2024 Jul 05.
Article en En | MEDLINE | ID: mdl-38972501
ABSTRACT
RATIONALE &

OBJECTIVE:

Chronic kidney disease (CKD) of unknown etiology (CKDUE) is one of the main global causes of kidney failure. While genetic studies may identify an etiology in these patients, few studies have implemented genetic testing of CKDUE in population-based series of patients which was the focus of the GENSEN. STUDY

DESIGN:

Case series. SETTINGS &

PARTICIPANTS:

818 patients aged ≤45 years at 51 Spanish centers with CKDUE, and either an estimated GFR <15 mL/min/1.73 m2 or treatment with maintenance dialysis or transplantation. OBSERVATIONS Genetic testing for 529 genes associated to inherited nephropathies using high-throughput sequencing (HTS). Pathogenic and/or likely pathogenic (P/LP) gene variants concordant with the inheritance pattern were detected in 203 (24.8%) patients. Variants in type IV collagen genes were the most frequent (COL4A5, COL4A4, COL4A3; 35% of total gene variants), followed by NPHP1, PAX2, UMOD, MUC1 and INF2 (7.3%, 5.9%, 2.5%, 2.5% and 2.5% respectively). Overall, 87 novel variants classified as P/LP were identified. The top 5 most common previously undiagnosed diseases were Alport syndrome spectrum (35% of total positive reports), genetic podocytopathies (19%), nephronophthisis (11%), autosomal dominant tubulointerstitial kidney disease (7%) and congenital anomalies of the kidney and urinary tract (CAKUT 5%). Family history of kidney disease was reported by 191 (23.3 %) participants and by 65/203 (32.0%) patients with P/LP variants.

LIMITATIONS:

Missing data. Selection bias resulting from voluntary enrollment.

CONCLUSIONS:

Genomic testing with HTS identified a genetic cause of kidney disease in approximately one quarter of young patients with CKDUE and advanced kidney disease. These findings suggest that genetic studies are a potentially useful tool for the evaluation of people with CKDUE.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Am J Kidney Dis Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Am J Kidney Dis Año: 2024 Tipo del documento: Article